0001437749-17-011352.txt : 20170615 0001437749-17-011352.hdr.sgml : 20170615 20170615171305 ACCESSION NUMBER: 0001437749-17-011352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170615 FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDWARDS MARK G CENTRAL INDEX KEY: 0001190429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 17914186 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 rdgdoc.xml FORM 4 (2017 OPTIONS) X0306 4 2017-06-15 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001190429 EDWARDS MARK G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Stock Option (Right to Buy) 2.30 2017-06-15 4 A 0 15000 0 A 2017-07-15 2027-06-14 Common Stock 15000 15000 D Issued pursuant to the 2011 Equity Incentive Plan. The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. 100% Acceleration upon Change of Control. /s/ Martha Adler, Attorney In Fact 2017-06-15